Solid-phase peptide synthesis: difference between revisions
Diff·revision 14 → 15·06:09, 27 Nov 2024
Difference between revision 14 and revision 15 of Solid-phase peptide synthesis. 6 lines changed; the page grew by 102 bytes.
| Revision 14 — 19:30, 15 Nov 2024 PreregPriya (talk) expand §Difficult sequences 3,861 bytes +484 | Revision 15 — 06:09, 27 Nov 2024 ArchiveBot (talk) bot: normalise temperature formatting 3,963 bytes +102 | ||
|---|---|---|---|
| 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 43 | 43 | ||
| + | 44 | == See also == | |
| + | 45 | * [[Peptide synthesis]] | |
| + | 46 | * [[Fmoc chemistry]] | |
| + | 47 | * [[Crude peptide]] | |
| + | 48 | * [[Resin cleavage]] | |
| + | 49 | ||
| 44 | {{DEFAULTSORT:Solid-phase peptide synthesis}} | 50 | {{DEFAULTSORT:Solid-phase peptide synthesis}} |
| 45 | [[Category:Peptide synthesis]] | 51 | [[Category:Peptide synthesis]] |